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Abstract
Background: Local microbial infections induced by multiple-drug-resistant bacteria in the orthopedic field can be
intractable, therefore development of new therapeutic modalities is needed. Photodynamic therapy (PDT) is a promising
alternative modality to antibiotics for intractable microbial infections, and we recently reported that PDT has the potential
to accumulate neutrophils into the infected site which leads to resolution of the infection. PDT for cancer has long been
known to be able to stimulate the innate and adaptive arms of the immune system.
Methodology/Principal Findings: In the present study, a murine methicillin-resistant Staphylococcus aureus (MRSA) arthritis
model using bioluminescent MRSA and polystyrene microparticles was established, and both the therapeutic (Th-PDT) and
preventive (Pre-PDT) effects of PDT using methylene blue as photosensitizer were examined. Although Th-PDT could not
demonstrate direct bacterial killing, neutrophils were accumulated into the infectious joint space after PDT and MRSA
arthritis was reduced. With the preconditioning Pre-PDT regimen, neutrophils were quickly accumulated into the joint
immediately after bacterial inoculation and bacterial growth was suppressed and the establishment of infection was
inhibited.
Conclusions/Significance: This is the first demonstration of a protective innate immune response against a bacterial
pathogen produced by PDT.
Citation: Tanaka M, Mroz P, Dai T, Huang L, Morimoto Y, et al. (2012) Photodynamic Therapy Can Induce a Protective Innate Immune Response against Murine
Bacterial Arthritis via Neutrophil Accumulation. PLoS ONE 7(6): e39823. doi:10.1371/journal.pone.0039823
Editor: Hossam M. Ashour, Wayne State University, United States of America
Received February 8, 2012; Accepted May 27, 2012; Published June 26, 2012
Copyright:  2012 Tanaka et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a Grant-in-Aid for Challenging Exploratory Research (23659628) from the Ministry of Education, Culture, Sports, Science
and Technology of Japan to Yuji Morimoto. Liyi Huang and Michael R. Hamblin were supported by U.S. National Institutes of Health grant R01AI050875 to Michael
R. Hamblin, and Tianhong Dai by an Airlift Research Foundation Extremity Trauma Research Grant (grant 109421). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: moyan@ndmc.ac.jp (YM); hamblin@helix.mgh.harvard.edu (MRH)
Introduction
Antibiotic therapy is still a mainstay of a treatment for microbial
infections in orthopedic fields. However, treatments for orthopedic
infectious disease, e.g. arthritis or osteomyelitis can be problematic
[1,2] due to various reasons: bone, cartilage and joint are naturally
aseptic: the blood supply to the tissues is lower: the frequent use of
artificial biomaterial implants made from metal or resin easily
facilitates the formation of a biofilm and reduces the response to
antibiotics. The occurrence of post-operative surgical-site infec-
tions (SSI) in bone and joint surgery has gradually decreased due
to the widespread use of sterile operation procedures and adequate
use of antibiotic therapy and recent data shows that the occurrence
of SSI after total knee arthroplasty (TKA) is less than 1% [1,2], for
example. However, once SSI does occur after orthopedic surgery,
adhesive biofilms are easily formed on the surface of metal or resin
biomaterials and the infection often becomes resistant to
conventional antibiotic therapy.
Furthermore, SSI caused by multidrug-resistant bacteria such as
methicillin-resistant Staphylococcus aureus (MRSA) continues to be
a serious problem. Bone or joint infections caused by multidrug-
resistant bacteria are extremely intractable; therefore patients who
suffer from these infections have to undergo invasive treatments
such as surgical excision and curettage or continuous irrigation in
addition to long-term antibiotic administration, resulting in
prolonged hospitalization and diminution in the quality of life
[3,4]. Excessive use of antibiotics encourages the spread of
multidrug-resistant bacteria, therefore new therapeutic modalities
as an alternative to antibiotics are needed. Although antibiotic
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preventive effect depends on the sensitivity of bacteria to
antibiotics and therefore SSI with multidrug-resistant bacteria
such as MRSA could not be eliminated.
In recent years, photodynamic therapy (PDT) has been
examined as an alternative approach to treat local microbial
infections. PDT originated from the development of photody-
namic agents (photosensitizers, PS) for clinical use in 1960s, and
has been clinically applied to cancer treatment e.g. for early stage
lung cancer [5]. PDT is considered as a non-invasive therapeutic
modality for malignant tumors. PS accumulated into the tumor
cells is activated by visible light, and the activated PS induces the
generation of reactive oxygen species, which damage the un-
wanted tissues or cells [6–10]. PDT has been clinically applied to
the treatment for early stage pulmonary, gastric and esophageal
carcinoma, and has been examined for an application to other
diseases such as retinal diseases [11,12] or cardiovascular disorders
[13,14]. Since the 1990s, PDT has attracted considerable attention
as a possible alternative approach for local microbial infection, and
there have been an increasing number of reports of applications of
PDT for infections with multidrug-resistant bacteria [15–20].
There have been no reports that described PDT-resistance of
bacteria, thus the application PDT for localized microbial
infections could be a new promising modality for bone and joint
infections regardless of the antibiotic sensitivity or multi-drug
resistance, therefore diminution of the patient’s quality of life could
be avoided. However, although favorable results of in vitro PDT for
cultured bacteria have been described in many reports, good
results in vivo in animal models of localized infections have only
been described in a few reports especially in the area of bone and
joint infectionss [19,20].
PDT is known to stimulate both the innate and adaptive arms of
the immune system and this aspect has been intensively in-
vestigated as part of the anti-cancer effect of PDT [21]. The acute
inflammatory effects of PDT produce cytokines and chemokines
that can attract and activate neutrophils [22], macrophages [23]
and dendritic cells [24]. Furthermore damage-associated molec-
ular patterns (DAMPS) can be produced by PDT-mediated tissue
damage that can produce further immune activation [25]. In some
circumstances this activation of innate immune cells leads to
production of tumor specific T-cells and B-cells and an antigen-
specific immune response develops [26]. Under favorable condi-
tions (e.g. the tumor expresses a tumor-rejection antigen) this
immune response can lead to rejection of tumor rechallenge [27],
cure of metastatic tumors [28] and even regression of distant
established tumors [26]. However to our our knowledge there
have been no reports of activation of the immune system towards
a microbial pathogen after PDT.
Bacterial phagocytosis by innate immune cells such as
neutrophils plays a crucial role in the elimination of invading
bacteria, especially Staphylococcus aureus [29–31]. Malfunction of the
phagocytic immune system therefore renders the host susceptible
to bacterial infections [32]. This fact is crucial when considering
the clinical situation of antimicrobial treatment. If a treatment
impairs the function of phagocytes in combating microbial
infection, the efficacy of the antimicrobial treatment might be
reduced, resulting in deterioration and prolongation of the
infection. Therefore, the undesirable influences of PDT, possible
cytocidal effects on phagocytes in particular, should be minimized
when considering the clinical application of PDT against local
microbial infection.
We have investigated the therapeutic effect of PDT for a murine
MRSA arthritis model focusing on the role of local host defense
mechanisms in the PDT response [33–35]. We recently demon-
strated that PDT using Photofrin could damage neutrophils as well
as bacteria in vitro [33], and in vivo PDT using Photofrin for murine
MRSA-induced arthritis showed a pronounced biphasic light dose
response [34]. Light doses that were too low and also light doses
that were too high were ineffective and there was an optimum
fluence to give the best antibacterial effect. PDT at a fluence that
could accumulate neutrophils into the infectious site led to
a favorable resolution of infection. Additionally, we demonstrated
that the PDT damage to neutrophils was minimized when
methylene blue or toluidine blue-O was used as a PS [35].
Methylene blue, in particular, had the best selectivity for bacteria
while preserving neutrophils, and additionally has a long wave-
length absorbance peak (664 nm), which could help to treat for
deep regional infections [36].
Based on these results, in this study, we selected methylene blue
as the optimal PS for antimicrobial PDT and examined the in vivo
therapeutic effect of PDT in a murine MRSA arthritis model in
the knee joint, focusing on the effects on host defense mechanisms
such as neutrophils (therapeutic PDT: Th-PDT). Furthermore, to
examine whether PDT could prevent microbial infection by
making use of its ability to stimulate host defense mechanisms, we
performed a preconditioning regimen of PDT before infection
(preventive PDT: Pre-PDT).
Prior to those examinations, we tried to resolve several problems
encountered in the previous study [33,34]. The problems were as
follows: firstly, the number of remaining viable MRSA in the joint
was decreased once the synovial fluid was collected, therefore the
time course of the severity of the infection could not be precisely
evaluated with the method of direct counting of colony-forming
units (CFU) of the MRSA in the synovial fluid collected from the
knee joint; secondly, even the control infections tended to resolve,
therefore the PDT effect could not be clearly demonstrated. To
resolve the first problem, we used luciferase-expressing bio-
luminescent MRSA [18,37] and in vivo bioluminescence imaging
and measured the intensity of bioluminescence to demonstrate
longitudinal progress of infection in the same mouse. To resolve
the second problem MRSA was inoculated with artificial resin
microparticles into the mouse knee joint to enable to establish
biofilm formation that leads to severe and intractable arthritis.
Results
Time Courses of a Mouse Model Using Resin
Microparticle (MP+ Group) and a Model without Resin
Microparticle (MP- Group)
Bioluminescence from the mouse knee joint was observed in
each MP+ and MP- group. The bioluminescent intensity in the
MP+ group was significantly higher than that in the MP- group
until 7 days after MRSA inoculation (Fig. 1). Histopathologically,
a bacterial colony was observed to be formed around the resin
microparticle, and leukocytes were outside of the boundary of the
infection and did not permeate into the border, indicating
localized bacterial growth with biofilm formation (Fig. 2). Accord-
ing to these results, we used the MP+ group model as a chronic
bacterial arthritis model in all the following experiments.
The Effect of Therapeutic PDT (Th-PDT)
The time course series of bioluminescent images of the intra-
articular lux-MRSA in each group was used for the evaluation of
the therapeutic effect of PDT. Bioluminescent intensity was not
significantly decreased in any of the control groups. On the other
hand, the bioluminescent intensity was significantly decreased in
the 50, 80 and 120 J/cm
2 group (Fig. 3a). Especially in the 50 and
80 J/cm
2 groups, the signal intensity was decreased at time points
PDT Can Protect against Bacterial Arthritis
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2 group showed the
lowest value throughout the period (Fig. 3a and 3b). The
bioluminescent intensity was not decreased in the other Th-PDT
groups. However, contrarily to our expectation, the biolumines-
cent intensity was not decreased immediately after PDT compared
to that before PDT in each group (Fig. 3a and 3b).
In the comparison of the mean area under the curve (AUC), the
value of the 50 J/cm
2 group was the lowest and the antimicrobial
effect was lessened when the light dose was either lower or higher
than 50 J/cm
2, which showed a biphasic light dose response curve.
The mean values of the AUC of the leg function score were
higher in the PDT groups from 20 to 120 J/cm
2 than that in the
PS-IR- group (Suppl. data Figs S1 a and S1 b). The AUC of the
erosion score were also higher in the PDT groups from 20 to
120 J/cm
2 than that in the PS-IR- group (Suppl. data Figs S1c
and S1d). Both the leg function score and the erosion score showed
a biphasic light dose response curve, indicating that Th-PDT in at
the appropriate dose could prevent function loss of the infected
knee joint.
Histopathological Changes in the Infected Knee Joints
Before and After Therapeutic PDT (Th-PDT)
Histopathological examination was performed for the evalua-
tion of neutrophil accumulation into the infected site after PDT.
One day after lux-MRSA inoculation, although nucleated cells
Figure 1. MRSA arthritis model followed by bioluminescence
imaging. (a) Time course of the bioluminescent signal of MRSA arthritis
models. (b) Images of bioluminescence in the model using micropar-
ticle (MP+ group) and in the model without microparticle (MP- group).
n=5 each. *P,0.05.
doi:10.1371/journal.pone.0039823.g001
Figure 2. MRSA arthritis model at days 1 and 5. a: Images of the bioluminescent MRSA-infected left knee joint of the MRSA arthritis model (PS-
IR- group). b: Histopathological images of MRSA colony with biofilm formation around the polystyrene particles. Blue arrows: resin microparticles,
yellow arrows: boundary of the MRSA colony. Bar=30 mm.
doi:10.1371/journal.pone.0039823.g002
PDT Can Protect against Bacterial Arthritis
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39823were accumulated into the joint space and synovium (Fig. 4a), only
a few GR-1-positive cells (neutrophils) were seen (Fig. 4b). In the
PS-IR- group, no remarkable change in the number of GR-1-
positive cells was seen at 2d or 5d, and the cells still remained in
the synovium at 5d (Fig. 4a and 4b). In the 5 J/cm
2 group, more
GR-1-positive cells were seen at 2d, and the cells still remained in
the hyperplastic synovium at 5d (Fig. 4a and 4b). In the 50 J/cm
2
group, a lot of GR-1-positive cells were seen in the joint space and
synovium at 2d. The synovium was hyperplastic at 5d; however,
few GR-1-positive cells were seen in the synovium at 5d (Fig. 4a
and 4b). In the 160 J/cm
2 group, synovial microvessels were
damaged and a large number of red blood cells were seen in the
joint space at 2d, indicating tissue damage by PDT (Fig. 4a). At 5d,
a GR-1 positive region was observed; however, it was a cell
accumulation surrounding a bacterial colony and a resin micro-
particle (Fig. 4b). These data showed that PDT at the correct dose
could accumulate neutrophils into the infected site, and correlated
with the resolution of the infection.
The Effect of Therapeutic PDT (Th-PDT) in the Neutrophil-
depletion Model
In the 50 J/cm
2 group with neutrophil-depletion using in-
travenous anti-GR-1 antibody, the consequent bioluminescent
intensity was maintained at high levels until 7d, which was similar
to that in the PS-IR- group (Fig. 5), indicating that therapeutic
effect of PDT was lost when neutrophils were depleted using
intravenous anti-GR-1 antibody.
The Effect of Preventive PDT (Pre-PDT) on Suppression of
the Infection
A suppressive effect on lux-MRSA arthritis was seen neither in
the control groups nor in the short interval Pre-PDT (22 h) group.
On the other hand, the bioluminescent intensity was significantly
decreased in the long interval Pre-PDT (21d) group, indicating
a suppression of bacterial growth and an inhibition of infection
when PDT was carried out one day before infection (Fig. 6a–c).
The AUC of both the leg function score and the erosion score in
the Pre-PDT (21d) group were significantly higher than that in
the control groups (Suppl. data Figs S2 a-d), indicating that the
long interval Pre-PDT could prevent function loss of the infected
knee joint.
Histopathological Changes in Infected Knee Joints Before
and After Preventive PDT (Pre-PDT)
Histopathological examination was performed to evaluate
when neutrophils were accumulated after Pre-PDT. In the Pre-
PDT (21d) group, the synovium and microvessels remained
intact and no accumulation of GR-1-positive cells (neutrophils)
was seen in the knee joint immediately after Pre-PDT and the
next day (just before lux-MRSA inoculation). However, many
GR-1-positive cells were accumulated and migrated into the
tissues around the microvessels only 2 hours after lux-MRSA
inoculation, and further large numbers of GR-1 positive cells
were accumulated in the joint space 1 day after the MRSA
inoculation (at 1d). Five days after inoculation, only a few GR-1
positive cells were seen in the hyperplastic synovium or joint
space, indicating the suppression of infection (Fig. 7). On the
other hand, in the PS-IR- group, few GR-1-positive cells had
migrated into the tissue around microvessels at 2 h. Although
many GR-1-positive cells were seen in the knee joint at 1d,
their number was still less than that in the Pre-PDT (21d)
group. The synovium was hyperplastic and many GR-1-positive
cells were seen even 5 d after the MRSA inoculation, indicating
the protraction of the course of arthritis (Fig. 7).
Figure 3. Effect of PDT doses on MRSA arthritis. a: Time course series of bioluminescent images after therapeutic PDT (Th-PDT) in each
irradiation energy group. b: A line graph of time courses of bioluminescent intensity after Th-PDT in each irradiation energy group. c: Comparison of
the area under the RLU curve (AUC) indicated in b. n=5 each. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0039823.g003
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depletion Model
In the Pre-PDT (21d) group with neutrophil-depletion using
intravenous anti-GR-1 antibody, the bioluminescent intensity was
maintained at high levels until 7d, which was similar to that in the
PS-IR- group (Fig. 8), indicating that the suppressive effect of Pre-
PDT on bacterial growth was lost when neutrophils were
decreased using neutralizing anti-GR-1 antibody.
Time Courses of Intra-articular Leukocyte Counts After
Preventive PDT (Pre-PDT)
In the Pre-PDT (21d) group, intra-articular leukocyte counts
were not increased immediately after Pre-PDT (at 21d) and 1
day after Pre-PDT (at 0d). However, counts were gradually
increased from 2 hours after lux-MRSA inoculation and reached
an extremely high level 1 day after the MRSA inoculation, then
gradually decreased (Fig. 9), correlating with the results shown
Figure 4. Histology of knees from mice with MRSA arthritis. Histopathological images of the intraarticular tissues of the knee joint in each Th-
PDT group (PS-IR-, 5, 50 and 160 J/cm
2). a: Hematoxilin-eosin staining, b: immunostaining using an anti-GR-1 antibody. Bar=50 mm.
doi:10.1371/journal.pone.0039823.g004
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intra-articular leukocytes were not increased 2 hours after
MRSA inoculation (at 2h), then gradually increased from 1 day
after the inoculation for the whole period of study until the last
observation, indicating the protraction of the course of arthritis
(Fig. 9).
Influences of Chemotactic Factors on the Effect of
Preventive PDT (Pre-PDT)
The suppressive effect of Pre-PDT for the development of
infection was abrogated by the administration of neutralizing
antibodies for chemotactic factors that are associated with the
neutrophil accumulation into the infectious site, except for an anti-
interleukin-6 (IL-6) antibody (Supp. data 3). In the comparison of
AUC, anti-macrophage-inflammatory-protein 2 (anti-MIP-2) an-
tibody significantly reduced the Pre-PDT effect (Fig. 10). The
other antibodies showed a tendency to reduce the Pre-PDT effect;
however, their AUC values were not significantly different from
that in the Pre-PDT (21d) group (Fig. 10). SN50 [38], which is an
inhibitor of nuclear factor-kappa B (NF-kB, a transcription factor
which is closely related to the initial inflammatory reaction), also
showed a tendency to reduce the Pre-PDT effect; however, the
AUC value was not significantly different from that in the Pre-
PDT (21d) group (Fig. 10).
Figure 5. Effect of anti-GR-1 antibody. Comparison of time courses of the bioluminescent intensity in the PS-IR- group, the anti-GR-1 antibody +
Th-PDT (50 J/cm
2) group and the Th-PDT (50 J/cm
2) group. n=5 each. **P,0.01.
doi:10.1371/journal.pone.0039823.g005
Figure 6. Effect of Pre-PDT on MRSA arthritis. a: Time course series of bioluminescent images after preventive PDT (Pre-PDT) in each group. b:
A line graph of time courses of bioluminescent intensity after Pre-PDT in each group. c: Comparison of the area under the RLU curve (AUC) of the
data indicated in b. n=5 each. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0039823.g006
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We established a murine chronic MRSA arthritis model using
a combination of bioluminescent MRSA and resin microparticles,
which allowed sequential non-invasive optical evaluation of the
course of the infection in an individual mouse and enabled us to
carry out a detailed examination of the PDT effects in an efficient
manner.
Using appropriate light doses, therapeutic PDT (Th-PDT)
successively reduced the bioluminescent intensity of lux-MRSA in
the knee joint from day of PDT for the succeeding 7 days, and
gave a therapeutic effect with 2-log10 reduction of bacterial
bioluminescence signal. The effective light dose ranged from 50 to
Figure 7. Histology of knees from Pre-PDT treated mice. Histopathological images of the intraarticular tissues of the knee joint in the
preventive PDT (Pre-PDT) group and the PS-IR- group (hematoxylin-eosin staining and immunostaining using an anti-GR-1 antibody). Bar=50 mm.
doi:10.1371/journal.pone.0039823.g007
Figure 8. Effect of anti-GR-1 antibody on Pre-PDT response. Comparison of time courses of bioluminescent intensity in the PS-IR- group, the
anti-GR-1 antibody + Pre-PDT (21d) group and the Pre-PDT (21d) group. n=5 each. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0039823.g008
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2, indicating that the therapeutic window of PDT using
methylene blue was broader than that of PDT using Photofrin
[34]. The administration of anti-GR-1 (anti-neutrophil) antibody
eliminated the therapeutic effect of PDT, indicating that the
therapeutic PDT using methylene blue exerted a therapeutic effect
for bacterial infection via the attraction and accumulation of
neutrophils into the infected region.
The bioluminescent intensity was not decreased immediately
after Th-PDT using any of the light doses, indicating that Th-PDT
did not exert a direct bacterial killing effect as expected. This
finding might be due to biofilm formation on the surface of the
resin microparticles that inhibited the binding of methylene blue
molecules to lux-MRSA cells and therefore led to the failure to
exert a direct bacterial killing. However, it has been reported that
PDT using methylene blue can disrupt biofilms [39–41] and this
might enable accumulated neutrophils to penetrate into the
biofilm and to kill the bacteria [42]. The therapeutic effect on
MRSA arthritis we hypothesized to be due to phagocytosis of the
bacteria by the accumulated and activated neutrophils stimulated
by PDT rather than via a direct bactericidal PDT killing.
These findings indicated that PDT using methylene blue could
strongly activate innate host defense mechanisms against a micro-
bial infection. Therefore, we hypothesized that PDT might
suppress bacterial growth and inhibit the establishment of infection
when performed as a protective pre-conditioning regimen. PDT
was conducted on a murine normal knee joint (preventive PDT:
Pre-PDT), and we examined the protective effect of Pre-PDT on
the in vivo development of infection. Pre-PDT performed on
normal tissue 1 day before the bacterial inoculation strongly
inhibited the subsequent bacterial growth and suppressed the
Figure 9. Time course of intrarticular leukocytes. Comparison of time courses of intraarticular leukocyte counts in the Pre-PDT (21d) group
and the PS-IR- group. n=5 each. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0039823.g009
Figure 10. Effect of blocking antibodies on Pre-PDT response. Comparison of the area under the RLU curve (AUC) in the Pre-PDT (21d) +
each antibody groups and the Pre-PDT (21d) group. These values were determined from the time courses shown in Figure S3. n=5 each. *P,0.05,
**P,0.01.
doi:10.1371/journal.pone.0039823.g010
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eliminated by administration of an intravenous anti-neutrophil
antibody, indicating that neutrophil activity played an important
role in the protection against infection by Pre-PDT as well as the
resolution of infection by the Th-PDT regimen.
The histopathological examination and the time course of intra-
articular leukocyte counts showed that although neither neutrophil
accumulation nor any other noticeable changes were seen in the
knee joint at 1 day after Pre-PDT, before bacteria were inoculated.
However neutrophils immediately migrated into the tissue around
microvessels and the number of leukocytes, mainly neutrophils, in
the knee joint began to increase within 2 hours after bacterial
inoculation. Generally, neutrophil accumulation into the regions
of bacterial infection needs at least 6 hours from bacterial invasion
because time is needed for the expression of chemotactic factors on
vascular endothelium and surrounding tissues [43,44]. Since Pre-
PDT carried out 24 hours previously (but not 2 hours previously)
enabled neutrophils to accumulate and migrate into the infectious
site within 2 hours after bacterial inoculation it is suggested that
a certain preparatory state of neutrophil priming was achieved.
Further investigation of the mechanisms of this neutrophil priming
should be performed.
We performed Pre-PDT with a set of neutralizing antibodies for
chemotactic factors, which are responsible for neutrophil activa-
tion and accumulation. All antibodies, except for the anti-IL-6
antibody, abrogated the protective effect of Pre-PDT on bacterial
growth; however, the extent of abrogation was limited compared
to that found in the group using anti-GR-1 and MIP-2 antibodies.
These results suggested that all the tested chemotactic factors
(except for IL-6) were involved in the effect of Pre-PDT to
stimulate innate immunity. In other words, Pre-PDT might
activate the whole sequential cascade for the accumulation,
migration and activation of neutrophils into the local infectious
site. MIP-2 in particular, is expressed by macrophages and
fibroblasts [45], therefore the initial mediators of the neutrophil-
mediated protective action of Pre-PDT might be macrophages or
synovial fibroblasts in the knee joint.
Nuclear-factor-kappa B (NF-kB) is a transcriptional factor and
closely related to the expression of cytokines and chemokines in
initial inflammation. There have been some reports that described
that PDT could directly activate NF-kB [46–48]. In our
examination, however, NF-kB inhibitor (SN50) did not signifi-
cantly decrease the effect of Pre-PDT (see Figure S3, indicating
that signaling cascades other than NF-kB activation were probably
responsible for the Pre-PDT effect. Further studies are needed to
define in more detail exactly which signaling pathways are
involved in the protective response against MRSA produced after
PDT. In particular the role of the transcription factor AP-1 should
be investigated and the exact role of IL6 needs to be explored.
The important (and sometimes crucial) role of neutrophils in the
therapeutic response of tumors to various PDT regimens has been
reported by several laboratories. De Vree et al [49] showed that
depletion of neutrophils using a neutralizing antibody abrogated
the tumoricidal effect of PDT, while increasing the number of
circulating neutrophils with injection of granulocyte colony-
stimulating factor potentiated the anti-tumor effect. Cecic et al
[50] found a rapidly developing systemic (as well as local)
neutrophilia in tumor-bearing mice after PDT with two different
PS that could be abrogated by inhibitors of complement
activation. These authors went on to show [51] that many
mediators such as IL-1beta, TNF-alpha, IL-6, IL-10, G-CSF and
KC, thromboxane, prostaglandins, leukotrienes, histamine, and
coagulation factors were involved in this phenomenon and all were
increased after complement activation after PDT. Although the
role of PDT-activated/stimulated neutrophils in the therapeutic
effects of PDT against cancer is established, the role of neutrophils
in the therapeutic effects of antimicrobial PDT had not been
previously reported before our studies in murine bacterial arthritis
[33–35].
To apply Th-PDT or Pre-PDT using methylene blue as
a therapeutic or preventive modality for clinical orthopedic
microbial infections, several further challenges remain: the
mechanism by which PDT using methylene blue potentiates
neutrophil accumulation into the infected site needs to be
elucidated; the development of a device that enables uniform
and efficient light irradiation in an infected joint is required; more
study of PS and light dosimetry would also be required; validation
would be requited using a large animal model of orthopedic
infection.
PDT may have some advantages compared with conventional
antibiotic therapy: PDT could have a potential to be effective for
infections caused by various bacteria regardless of antibiotic
susceptibility; PDT could be applied as a preventive (prophylactic)
strategy for a surgical-site infection after orthopedic surgery such
as total knee arthroplasty, as well as a therapeutic modality for
a traumatic or a post-surgical infection in orthopedics. PDT could
be a new strategy for both the treatment and prevention of bone
and joint bacterial infections more widely than the knee, as well as
for intractable arthritis caused by multiple-drug-resistant bacteria.
In conclusion, therapeutic PDT using methylene blue exerted
a promising therapeutic effect in a murine chronic MRSA arthritis
model via neutrophil accumulation and migration. Preventive
PDT used as a pre-conditioning regimen before bacterial in-
oculation suppressed the bacterial growth and inhibited the
establishment of infection. This is the first demonstration of
a protective innate immune response against a microbial pathogen
being induced by PDT. This study did not evaluate the adaptive
immune response (if any) induced after PDT for MRSA infection.
Further studies should evaluate possible changes in Th-1, Th-2
and Th-17 T-cells and antibodies from B-cells.
Materials and Methods
Ethics Statement
This study was approved by the Subcommittee on Research
Animal Care (IACUC) of Massachusetts General Hospital, USA
(protocol 2005N000111) and the Institutional Review Board for
the Care of Animal Subjects at the National Defense Medical
College, Japan (protocols 08007 and 11008).
Mouse Model of Intractable MRSA Arthritis Using
Bioluminescent MRSA and Resin Microparticle
Stably bioluminescent MRSA Xen31 (Caliper Life Sciences,
Alameda, CA: lux-MRSA) [18,37] and resin microparticle (MP)
made of polystyrene (Copolymer Microsphere Suspensions 7000
Q3.2 mm, Thermo Scientific Particle Technology, Fremont, CA)
were used. The bacteria (lux-MRSA) were grown overnight in
brain heart infusion (BHI) medium at 37uC with shaking at
100 rpm. Cell growth was assessed with an Evolution 300 UV-Vis
Spectrophotometer (Thermo Scientific, Waltham, MA). When
cultures reached an optical density (OD600) of 0.8, which
corresponds to a bacterial cell density of 10
8 CFU/mL, they were
washed and resuspended in phosphate-buffered saline (PBS)
(Dulbecco) at 1610
10 CFU/mL. Eight to nine-week-old male
C57BL/6 mice (Charles River Laboratories, Wilmington, MA)
were anesthetized by intraperitoneal (i.p.) injections of a cocktail
composed of 100-mg/kg ketamine and 10-mg/kg xylazine and the
left knees were shaved. According to the method described
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(1610
8 CFU) and MP (2.5% volume) was intra-articularly injected
into the left knee joint through the midline of the patellar ligament
using a syringe with a 29 G needle (MP+ group). As a control,
10 mL of PBS suspension containing lux-MRSA (1610
8 CFU) but
not MP was intra-articularly injected into the left knee joint (MP-
group), and the severity of arthritis was compared with that of
MP+ group.
Evaluation of MRSA Arthritis by a Measurement of
Bioluminescent Intensity
An image intensifier-equipped CCD photon-counting camera
(Model C2400-30H; Hamamatsu Photonics, Bridgewater, NJ)
mounted in a light-shielded specimen chamber, a computer system
with Microsoft Windows 98 through an image processor (Argus-
50, Hamamatsu Photonics) and an Argus-50 control program
(Hamamatsu Photonics) was used to acquire images and to process
the image data collected. As described [18,19,52], entire photon
count of the left knee was quantified as relative luminescence units
(RLUs) and was displayed in a false color scale ranging from pink
(most intense) to blue (least intense). The bit range was fixed at 1–3
and the collecting time was fixed at 3 minutes.
Photodynamic Therapy Using Methylene Blue
Therapeutic PDT (Th-PDT). The day in which lux-MRSA
and resin microparticle (MP) were inoculated into the knee joint
was defined day 0 (0d). Twenty-four hours after the inoculation (at
1d), 10 mL of PBS solution of methylene blue (100 mM) was
injected into the joint followed by immediate irradiation using
a xenon light source with a bandpass filter (wavelength of
660615 nm, LumaCare, Newport, CA). The fluence rate was
fixed at 100 mW/cm
2 and six different fluences ranging from 5 to
160 J/cm
2 were used (5, 20, 50, 80, 120 and 160 J/cm
2 in each
group of mice, n=5). Three other groups of mice were prepared as
controls: (1) an IR- group, which received MB solution without
subsequent photoirradiation, (2) a PS- group, which received
photoirradiation without MB injection, (3) a PS-IR- group, which
receive neither MB nor irradiation.
Bioluminescent intensity was measured 1 day after the in-
oculation of lux-MRSA with MP (at 1d), immediately after PDT
(after PDT) and 2, 3, 5 and 7 days after the inoculation of lux-
MRSA and MP (at 2d, 3d, 5d and 7d). The bioluminescent
intensity value of each mouse at 1d was defined ‘1’ and the values
of the other time points were expressed as relative values.
Preventive PDT (Pre-PDT). The day in which lux-MRSA
and resin microparticle (MP) were inoculated into the knee joint
was defined day 0 (0d). Twenty-four hours (at 21d) or two hours
(at 22h) before the inoculation, 10 mL of PBS solution of
methylene blue (concentration of 100 mM) was injected into the
joint followed by immediate irradiation using the light source in
the fluence of 50 J/cm
2 (a Pre-PDT (21d) group and a Pre-PDT
(22h) group). Bioluminescent intensity was measured 2 hours (at
2h), 1, 2, 3, 5 and 7 days (at 1d, 2d, 3d, 5d and 7d) after the
inoculation of lux-MRSA with MP. The bioluminescent intensity
value of each mouse at 2h was defined ‘1’ and the values of the
other time points were expressed as relative values.
Follow-up of Leg Function and Local Erosion
The motility of each leg of the mice was evaluated for function
and marked on the following scale 0–4 (leg function score) [19]:
4= perfectly normal leg in appearance and motion; 3= slight
limp, slight impairment in movement; 2= significant impairment
in movement, mouse cannot walk normally; 1= leg is paralyzed
and dragged behind mouse; 0= legs suffers from frank necrosis or
is absent. Additionally, their legs were observed for local erosion
and marked on the following scale from 0–4 (erosion score): 4=
no erosion with normal skin; 3= slight erythema or discolored
skin; 2= skin necrosis with scabbing; 1= diffuse skin defect with
exposure of subcutaneous tissue; 0= exposure of bone or absence
of the leg.
Histopathological Evaluation
Therapeutic PDT (Th-PDT). Mice in the PS-IR- group, the
5, 50 and 160 J/cm
2 group were sacrificed at 1d, 2d or 5d (n=3).
Knee joints were extracted and fixed with 10% formaldehyde
solution for 48 hours and then decalcified with 10% ethylenedia-
minetetraacetic acid (EDTA)-2Na solution (pH 7) for 14 days. The
tissue samples were then processed for hematoxylin-eosin (HE)
staining and immunostaining for neutrophil-specific staining using
a rat anti-mouse LY-6G/GR-1 antibody (SouthernBiotech,
Birmingham, AL), a VECTASTAIN Elite ABC Kit (Vector
Laboratories, Burlingame, CA) and a VECTOR NovaRED
Substrate Kit (Vector Laboratories).
Preventive PDT (pre-PDT). Mice in the Pre-PDT (21d)
group were sacrificed immediately after Pre-PDT (at 21d), just
before MRSA inoculation with MP (at 0d), 2 hours (at 2h), 1 day
(at 1d) and 5 days (at 5d) after inoculation (n=3). Knee joints were
processed as described above. Mice in the PS-IR- group were
sacrificed at 0d (= normal knee joint), 2h, 1d and 5d and the knee
joint was processed as described above.
PDT Effect in Neutrophil-depletion Models
Therapeutic PDT (Th-PDT). Mice in the 50 J/cm
2 group
were administrated rat anti-mouse LY-6G/GR-1 antibody (4 mg/
kg at 1d, 2 mg/kg at 2d and 2 mg/kg at 3d) by an intravenous
injection [53] and time course-bioluminescent intensity of the knee
joint was evaluated (n=5).
Preventive PDT (Pre-PDT). Mice in the Pre-PDT 21d
group were received rat anti-mouse LY-6G/GR-1 antibody
(4 mg/kg at 21d, 2 mg/kg at 0d and 2 mg/kg at 1d) by an
intravenous injection and time course-bioluminescent intensity of
the knee joint was evaluated (n=5).
Time Courses of Intra-articular Leukocyte Counts after
Preventive PDT (Pre-PDT)
Two microliters of synovial fluid was collected from the knee
joint of a mouse in the Pre-PDT (21d) group, and the numbers of
leukocytes in the synovial fluid at 21d, 0d, 2h, 1d or 5d were
estimated by the methods described previously [33,34]. The
numbers of intraarticular leukocytes in the PS-IR- group at 0d, 2h,
1d or 5d were also estimated by the same methods (n=5 in each
group).
Neutralization of Chemotactic Factors in the Preventive
PDT (Pre-PDT)
Involvement of each chemotactic factor was evaluated using
neutralizing antibody [53]. Mice in the Pre-PDT (21d) group
were administrated each antibody described below by an
intravenous injection (4 mg/kg at 21d, 2 mg/kg at 0d and
2 mg/kg at 1d), and the bioluminescent intensity of the knee joint
was sequentially evaluated: a mouse anti-mouse interleukin 1-beta
(IL-1b) antibody (Thermo Scientific Pierce, Rockford, IL), a goat
anti-mouse tumor necrosis factor alpha (TNF-a) antibody (Sigma-
Aldrich), a rabbit anti-mouse interleukin 6 (IL-6) antibody
(Thermo Scientific Pierce), a goat anti-mouse macrophage in-
flammatory protein 2 (MIP-2) antibody (Sigma-Aldrich), a rabbit
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Scientific Pierce), a hamster anti-mouse intercellular adhesion
molecule 1 (ICAM-1) antibody (BD Biosciences, San Diego, CA)
and a rat anti-mouse E-selectin antibody (BD Biosciences) (n=5in
each group).
In addition, mice in the Pre-PDT (21d) group were given SN50
[38] (Enzo LifeSciences, Plymouth Meeting, PA), which is an
inhibitor of nuclear factor-kappa B (NF-kB), one of the
transcription factor for initial inflammatory reaction, by an
intravenous injection (4 mg/kg at 21d, 2 mg/kg at 0d and
2 mg/kg at 1d), and the bioluminescent intensity of the knee joint
was sequentially evaluated (n=5). Integral values of the time
courses of bioluminescent intensity at from 2h to 7d were
calculated and expressed as the area under the curve (AUC).
AUC in each group were statistically compared to that in the PS-
IR- group as described previously [18].
Statistical Analysis
All the data are expressed as means 6 SE. Mean values in each
group or AUC were used for statistical analysis. One-way
repeated-measures analysis of variance (ANOVA) test followed
by Dunnett’s post hoc test was used for data analysis of time
courses. Two-way repeated-measures ANOVA test followed by
paired t-test was used for data analysis of intraarticular leukocyte
counts. One-way ANOVA test followed by Dunnett’s post hoc test
was used for data analysis of AUC. SPSS ver.16 was used for each
data analysis. P-values ,0.05 were considered statistically
significant.
Supporting Information
Figure S1 Leg function and erosion scores after Th-
PDT. a: Time courses of the leg function score after therapeutic
PDT (Th-PDT) in each irradiation energy group. b: Comparison
of the area under the curve (AUC) of the data indicated in b. c:
Time courses of the erosion score. d: Comparison of the area
under the curve (AUC) of the data indicated in c. n=5 each.
*P,0.05, **P,0.01.
(TIFF)
Figure S2 Leg function and erosion scores after Pre-
PDT. a: Time courses of the leg function score after preventive
PDT (Pre-PDT) in each group. b: Comparison of the area under
the curve (AUC) of the data indicated in b. c: Time courses of the
erosion score. d: Comparison of the area under the curve (AUC) of
the data indicated in c. n=5 each. **P,0.01.
(TIFF)
Figure S3 Effect of neutralizing antibodies on biolumi-
nescence in Pre-PDT. Serial time courses of the bioluminescent
intensity in each Pre-PDT group using neutralizing antibodies for
chemotactic factors.
(TIFF)
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